Seraina Faes

1.2k total citations
23 papers, 628 citations indexed

About

Seraina Faes is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Seraina Faes has authored 23 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Seraina Faes's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Enzyme function and inhibition (3 papers). Seraina Faes is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Enzyme function and inhibition (3 papers). Seraina Faes collaborates with scholars based in Switzerland, Italy and India. Seraina Faes's co-authors include Olivier Dormond, Nicolas Demartines, Émilie Uldry, Catherine Pythoud, Mirija Svaldi, Manfred Mitterer, Marc Dufour, Jean‐Christophe Stehle, Igor Letovanec and Nicolò Riggi and has published in prestigious journals such as Annals of Surgery, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Seraina Faes

22 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seraina Faes Switzerland 12 370 156 149 77 68 23 628
Liping Dou China 17 484 1.3× 113 0.7× 241 1.6× 71 0.9× 75 1.1× 101 962
Muqing Yang China 17 435 1.2× 138 0.9× 216 1.4× 94 1.2× 84 1.2× 41 855
Katharina Tschoep Germany 8 336 0.9× 138 0.9× 112 0.8× 63 0.8× 136 2.0× 11 719
Yifu He China 16 283 0.8× 238 1.5× 191 1.3× 131 1.7× 177 2.6× 78 717
Spyridon Davakis Greece 10 251 0.7× 109 0.7× 91 0.6× 96 1.2× 137 2.0× 50 629
Sylvie Shen Australia 14 447 1.2× 202 1.3× 177 1.2× 37 0.5× 171 2.5× 26 840
Shengmian Li China 11 360 1.0× 156 1.0× 196 1.3× 104 1.4× 86 1.3× 34 615
WEN-SHIN CHANG Taiwan 12 250 0.7× 125 0.8× 158 1.1× 37 0.5× 57 0.8× 74 527
Marija Mihajlović Serbia 10 196 0.5× 319 2.0× 88 0.6× 93 1.2× 66 1.0× 38 735

Countries citing papers authored by Seraina Faes

Since Specialization
Citations

This map shows the geographic impact of Seraina Faes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seraina Faes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seraina Faes more than expected).

Fields of papers citing papers by Seraina Faes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seraina Faes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seraina Faes. The network helps show where Seraina Faes may publish in the future.

Co-authorship network of co-authors of Seraina Faes

This figure shows the co-authorship network connecting the top 25 collaborators of Seraina Faes. A scholar is included among the top collaborators of Seraina Faes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seraina Faes. Seraina Faes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kefleyesus, Amaniel, Seraina Faes, Daniel Clerc, et al.. (2025). Anal Cancer Screening: 10-Year Experience of a Specialized Outpatient Clinic. Cancers. 17(2). 193–193. 1 indexed citations
3.
Faes, Seraina, Pénélope St-Amour, Basile Pache, et al.. (2024). Concomitant Cervical and Anal Screening for Human Papilloma Virus (HPV): Worth the Effort or a Waste of Time?. Cancers. 16(20). 3534–3534. 1 indexed citations
4.
Roesel, Raffaello, et al.. (2023). Ondansetron for Low Anterior Resection Syndrome (LARS): A Double Blind, Placebo Controlled, Cross-Over, Randomized Study. British journal of surgery. 110(Supplement_5). 2 indexed citations
5.
Hübner, Martin, et al.. (2023). Dépistage du cancer anal. Expérience d’une décennie de consultation spécialisée. Revue Médicale Suisse. 19(831). 1186–1190. 1 indexed citations
6.
Popeskou, Sotirios Georgios, et al.. (2023). Ondansetron for Low Anterior Resection Syndrome (LARS). Annals of Surgery. 279(2). 196–202. 3 indexed citations
7.
Faes, Seraina, et al.. (2021). Elective Surgery for Diverticulitis in Swiss Hospitals. Frontiers in Surgery. 8. 717228–717228. 1 indexed citations
8.
Faes, Seraina, Nicolas Demartines, & Olivier Dormond. (2021). Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives. Frontiers in Cell and Developmental Biology. 9. 636037–636037. 25 indexed citations
10.
Faes, Seraina, Martin Hübner, Nicolas Demartines, & Dieter Hahnloser. (2020). Cytokine clearance in serum and peritoneal fluid of patients undergoing damage control surgery with abdominal negative pressure therapy for abdominal sepsis. SERVAL (Université de Lausanne). 6(1). 31–38. 3 indexed citations
11.
Faes, Seraina, et al.. (2019). Short‐ and long‐term outcomes of laser haemorrhoidoplasty for grade IIIII haemorrhoidal disease. Colorectal Disease. 21(6). 689–696. 28 indexed citations
12.
Faes, Seraina, et al.. (2019). Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growth. Biochemical and Biophysical Research Communications. 513(3). 546–552. 2 indexed citations
13.
Faes, Seraina, Nicolas Demartines, & Olivier Dormond. (2017). Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. Oxidative Medicine and Cellular Longevity. 2017(1). 1726078–1726078. 69 indexed citations
14.
Faes, Seraina, et al.. (2017). Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy. Cancers. 9(11). 152–152. 40 indexed citations
15.
Faes, Seraina, Émilie Uldry, Catherine Pythoud, et al.. (2016). Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors. Molecular Cancer. 15(1). 78–78. 52 indexed citations
16.
Faes, Seraina, Émilie Uldry, Catherine Pythoud, et al.. (2016). Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors. Oncotarget. 7(24). 36666–36680. 22 indexed citations
17.
Faes, Seraina & Olivier Dormond. (2015). PI3K and AKT: Unfaithful Partners in Cancer. International Journal of Molecular Sciences. 16(9). 21138–21152. 202 indexed citations
18.
Faes, Seraina & Olivier Dormond. (2015). Systemic Buffers in Cancer Therapy: The Example of Sodium Bicarbonate; Stupid Idea or Wise Remedy?. Medicinal Chemistry. 5(12). 13 indexed citations
19.
Dufour, Marc, et al.. (2014). PGE2-induced colon cancer growth is mediated by mTORC1. Biochemical and Biophysical Research Communications. 451(4). 587–591. 37 indexed citations
20.
Svaldi, Mirija, et al.. (2001). Procalcitonin‐reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. British Journal of Haematology. 115(1). 53–57. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026